Indications

Person standing in the forest.
Person standing in the forest.

WITH BREYANZI®, SUCCESS IS IN YOUR BLOOD

Home > Starting Breyanzi

THE KEY TO BREYANZI IS YOU

Your white blood cells (T cells) are combined with a chimeric antigen receptor ⁠(CAR) so they can better locate and fight your cancer cells. Learn more about each step in the CAR T treatment process.

CAR T consultation

You’ll have a consultation at a certified treatment center, where you'll be evaluated to make sure you’re a candidate for Breyanzi.

If eligible based on your consultation, you will be scheduled to have your blood drawn, a process called apheresis (also referred to as leukapheresis). After your blood is drawn, your white blood cells (T cells), a type of cell in your immune system, will be collected while the other parts of your blood are returned into your body. Apheresis can be done in 1 day and usually takes 2 to 6 hours.

Illustration of a patient undergoing apheresis in a CAR T treatment center

Your white blood cells (T cells) will be sent to a manufacturing site to become Breyanzi CAR T cells

While at the manufacturing site, CARs (receptors or hooks) are added to your white blood cells (T cells) to make the Breyanzi CAR T cells that are unique to you. The CAR T cell can then find and fight specific cancer cells. During this time, your doctor may prescribe other treatments for your cancer.

Illustration of a T cell combined with CAR receptor creating CAR T cell.

Your Breyanzi CAR T cells are infused back into your body

Illustrated IV bag and calendar indicating 3 days of low-dose chemothapy treatment before infusion.

Before your infusion:

Before your Breyanzi infusion, you’ll receive a low-dose chemotherapy called lymphodepleting chemotherapy for 3 days to help prepare your body for Breyanzi.

The low-dose chemotherapy is given 2–7 days before receiving Breyanzi.

Illustrated CAR T treatment center.

During your infusion:

Breyanzi is given as infusions of 2 different cell types. These infusions are given one after the other, and each takes less than 15 minutes to infuse, but times may vary.

Breyanzi will be given at a certified treatment center by a specially trained healthcare team. Your healthcare provider will decide if you need to stay in the hospital or if you can be discharged after treatment.

Illustrated car and house, showing that the patient will be closely monitored for side effects following infusion.

After your infusion:

You’ll be closely monitored for side effects following your Breyanzi infusion.

During the first week, you will be monitored daily by the facility where you received Breyanzi. Plan to stay close to this location for at least 4 weeks after infusion.

You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control and it is safe for you to leave.

During this time, you or your care partner may have questions like “What do I pack?” or “How will we cover travel expenses?” We can help you answer these questions and provide resources. Sign up for our Cell Therapy 360® program to learn more or check out our other helpful resources.

Initial follow-up monitoring: After your infusion, you will be monitored every day for a week. Plan to stay close to the treatment center for at least 4 weeks.

Long-term monitoring: Your healthcare provider will want to do blood tests to follow your progress. Some patients treated with Breyanzi may develop other cancers. Your healthcare team will provide lifelong monitoring for these cancers. It's important that you have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

Breyanzi Live from the CAR T Treatment Center Video

Watch the treatment process from beginning to end

This video outlines the infusion process in its entirety to help you and your loved ones better understand what to expect.

“I remember watching while they were putting the CAR T cells into me. I felt hopeful that things were going to start turning around. This was our fresh start.”

—Nick, a real Breyanzi patient



Bristol Myers Squibb® logo

© 2024 Juno Therapeutics, Inc., a Bristol Myers Squibb company. All Rights Reserved.

BREYANZI and the related logo are trademarks of Juno Therapeutics, Inc., a Bristol Myers Squibb company.



2009-US-2400823, 2009-US-2400827 12/24